Cuál es el precio por Pharmanutra S.p.A. (PHN)

Precio por Pharmanutra S.p.A. (PHN) es de$97.03

Cuál es la capitalización de mercado por Pharmanutra S.p.A. (PHN)

Capitalización de mercado por Pharmanutra S.p.A. (PHN) es $929.06M

Ingresos de Pharmanutra S.p.A. (PHN)

Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.

Año	Ingresos	Cambiar
Not enough data for the provided dates.

Año

Ingresos

Cambiar

Not enough data for the provided dates.

Empresa	Ingresos	Diferencia de ingresos	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Empresa

Ingresos

Diferencia de ingresos

País